Total Payments
$3,209
2024 Payments
$1,469
Companies
31
Transactions
186
Medicare Patients
792
Medicare Billing
$48,633
Payment Breakdown by Category
Food & Beverage$3,109 (96.9%)
Education$99.99 (3.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,109 | 185 | 96.9% |
| Education | $99.99 | 1 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $419.76 | 18 | $0 (2024) |
| Amgen Inc. | $407.86 | 29 | $0 (2024) |
| GlaxoSmithKline, LLC. | $396.20 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $337.59 | 18 | $0 (2024) |
| PFIZER INC. | $255.79 | 17 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $196.98 | 8 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $192.27 | 12 | $0 (2024) |
| ABBVIE INC. | $124.01 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $112.40 | 6 | $0 (2024) |
| Daiichi Sankyo Inc. | $90.76 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,469 | 82 | AstraZeneca Pharmaceuticals LP ($216.35) |
| 2023 | $1,288 | 80 | GlaxoSmithKline, LLC. ($251.82) |
| 2022 | $452.03 | 24 | Astellas Pharma US Inc ($125.80) |
All Payment Transactions
186 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: UROLOGY | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Cardio-renal | ||||||
| 11/08/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Bone Health | ||||||
| 11/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Biological | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: UROLOGY | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Inflammation | ||||||
| 10/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/04/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $15.34 | General |
| 10/03/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $18.73 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Inflammation | ||||||
| 09/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Biological | ||||||
| 09/05/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Genetic Disease | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 389 | 483 | $68,865 | $33,021 |
| 2022 | 13 | 403 | 446 | $35,285 | $15,612 |
Total Patients
792
Total Services
929
Medicare Billing
$48,633
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 208 | $29,120 | $14,145 | 48.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 129 | $12,900 | $5,367 | 41.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $12,005 | $4,135 | 34.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 33 | 33 | $5,775 | $3,851 | 66.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 22 | 24 | $5,280 | $3,360 | 63.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 20 | 20 | $3,130 | $2,054 | 65.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 20 | 20 | $655.00 | $108.18 | 16.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 95 | $12,350 | $6,178 | 50.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 31 | $6,045 | $2,880 | 47.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $4,800 | $1,930 | 40.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 37 | 37 | $2,960 | $1,486 | 50.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 32 | 63 | $1,890 | $1,022 | 54.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 22 | 22 | $770.00 | $359.04 | 46.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 44 | 46 | $1,150 | $350.06 | 30.4% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 20 | 20 | $1,200 | $315.00 | 26.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 18 | 18 | $360.00 | $291.60 | 81.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 25 | 26 | $1,300 | $269.10 | 20.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 32 | 32 | $1,600 | $265.28 | 16.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 11 | 11 | $715.00 | $181.06 | 25.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 26 | 29 | $145.00 | $85.26 | 58.8% |
About Dr. Stephen Pace, MD
Dr. Stephen Pace, MD is a Pediatrics healthcare provider based in Jonesboro, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2018. The National Provider Identifier (NPI) number assigned to this provider is 1487141420.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Pace, MD has received a total of $3,209 in payments from pharmaceutical and medical device companies, with $1,469 received in 2024. These payments were reported across 186 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,109).
As a Medicare-enrolled provider, Pace has provided services to 792 Medicare beneficiaries, totaling 929 services with total Medicare billing of $48,633. Data is available for 2 years (2022–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Student in an Organized Health Care Education/Training Program, Internal Medicine
- Location Jonesboro, AR
- Active Since 04/16/2018
- Last Updated 07/05/2022
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1487141420
Products in Payments
- TRELEGY ELLIPTA (Drug) $340.04
- Veozah (Drug) $246.41
- ELIQUIS (Drug) $222.11
- Otezla (Drug) $214.53
- FARXIGA (Drug) $203.49
- XIFAXAN (Drug) $192.27
- REXULTI (Drug) $191.66
- AIRSUPRA (Drug) $134.10
- EVENITY (Biological) $112.09
- INJECTAFER (Drug) $90.76
- Repatha (Biological) $81.24
- Myrbetriq (Drug) $73.36
- GEMTESA (Drug) $72.34
- Kerendia (Drug) $68.02
- UBRELVY (Drug) $65.31
- MOUNJARO (Drug) $61.62
- NURTEC ODT (Drug) $56.81
- ABILIFY MAINTENA (Drug) $53.45
- VRAYLAR (Drug) $45.01
- QUTENZA (Drug) $39.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Jonesboro
Dr. Kevin Rouse, M.d, M.D
Pediatrics — Payments: $7,759
Pediatrics $7,759
Dr. Greg Buxton, M.d, M.D
Pediatrics — Payments: $2,242
Pediatrics $2,242
Robert Hornbeck, M.d, M.D
Pediatrics — Payments: $1,716
Pediatrics $1,716
Dr. Marvin Beck, M.d, M.D
Pediatrics — Payments: $1,473
Pediatrics $1,473
Dr. Amy Bailey, Md, MD
Pediatrics — Payments: $1,288
Pediatrics $1,288
Ms. Tonya Slusher, Md, MD
Pediatrics — Payments: $1,085
Pediatrics $1,085